Update to the Vosoritide (Voxzogo TM) indication in USA On October 20, 2023 US Food and Drug Administration (FDA) has extended approval of Voxzogo to children…
Read More
New Meds and Tech from PES Drugs and Therapeutics committee SKYTROFA® Anna Ryabets-Lienhard, DO, Christine Yu, MD, Emily Breidbart, MD In August 2021, FDA approved…
Read More
EVOLOCUMAB (REPATHA) Brenda Kohn MD, Dania Al-Hamad MD, Ambika P. Ashraf MD On September 24, 2021, Amgen announced that the FDA approved evolocumab (Repatha) as an adjunct…
Read More
Prepared on behalf of the PES Drugs and Therapeutics Committee by Kristal Matlock, MD, Dania Al-Hamad, MD, Vandana Raman, MD and Amit Lahoti, MD FDA approval…
Read More
Brief Therapeutic Update from PES Drugs and Therapeutics Committee (THYQUIDITYTM) THYQUIDITYTM is a liquid levothyroxine preparation that is FDA approved for (i) treatment of congenital or…
Read More
Not a member yet? Join the largest Pediatric Endocrine community and unlock a host of tools, resources, and enhance your network! Click here to learn more.
Approval of generic glucagon for management of hypoglycemia Prepared by: Kristal Matlock, Preneet Cheema Brar, Molly Regelmann UpToDate as of: 1/20/2021 On December 28, 2020, the…
Read More
Setmelanotide Prepared by: Anshu Gupta, MD, MS and Brenda Kohn, MD Up-to-date as of December 14, 2020 On November 27, 2020, setmelanotide (IMCIVREE™; Rhythm Pharmaceuticals, Inc.),…
Read More
Saxenda (Liraglutide) Approved for Adolescent Obesity Prepared by: Laura Page, MD and Shilpa Mehta, MD Up to date as of December 10, 2020 On December 4,…
Read More
Hydrocortisone Granules (Alkindi Sprinkle) Prepared by: Takara Stanley, Seth Marks and Kyriakie Sarafoglou Up to date as of: November 4, 2020 On September 29, 2020, the…
Read More